SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 662.92 |
| Enterprise Value ($M) | 504.21 |
| Book Value ($M) | 508.55 |
| Book Value / Share | 6.01 |
| Price / Book | 1.30 |
| NCAV ($M) | 401.10 |
| NCAV / Share | 4.74 |
| Price / NCAV | 1.65 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.34 |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | -0.33 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.05 |
| Current Ratio | 13.05 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 556.46 |
| Assets | 663.91 |
| Liabilities | 155.35 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | |||
| 13G/A | Millennium Management Llc | |||
| 13G/A | ARK Investment Management LLC | |||
| 13G | Biotechnology Value Fund L P | 8.20 | ||
| 13G/A | Vanguard Group Inc | 4.73 | 0.00 | |
| 13G/A | BlackRock, Inc. | 8.60 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 233,424 | 1,095,282 | 21.31 | |
| 142,013 | 953,591 | 14.89 | |
| 162,028 | 1,003,523 | 16.15 | |
| 212,128 | 1,387,204 | 15.29 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TYRA – Tyra Biosciences, Inc. | UBX – Unity Biotechnology, Inc. |
| UTHR – United Therapeutics Corporation | VIGL – Vigil Neuroscience, Inc. |
| VIR – Vir Biotechnology, Inc. |
Financial data and stock pages provided by
Fintel.io